Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 71.4%
Negative

Positive
Proactive Investors
18 hours ago
Zynex appoints industry veteran Bret Wise to its Board, will also serve as Audit Committee chair
Zynex Inc (NASDAQ:ZYXI) announced the appointment of Bret Wise to its Board of Directors. He will also serve as chair of the Audit Committee.
Zynex appoints industry veteran Bret Wise to its Board, will also serve as Audit Committee chair
Neutral
PRNewsWire
yesterday
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair
ENGLEWOOD, Colo. , Oct. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of Bret Wise to its Board of Directors.
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair
Neutral
GlobeNewsWire
18 days ago
ZYNEX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Sept. 27, 2025 (GLOBE NEWSWIRE) -- What's Happening: Bragar Eagel & Squire, P.C.
ZYNEX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Neutral
GlobeNewsWire
1 month ago
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C.
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Positive
Proactive Investors
1 month ago
Zynex welcomes Steve Dyson as CEO, adds to leadership team
Zynex Inc (NASDAQ:ZYXI), a medical technology company specializing in non-invasive devices for pain management, rehabilitation, and patient monitoring, announced the arrival of Steven Dyson as its new CEO, along with the appointment of several senior leaders. The company announced back in June that Dyson had been selected as incoming CEO.
Zynex welcomes Steve Dyson as CEO, adds to leadership team
Neutral
PRNewsWire
1 month ago
Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles
ENGLEWOOD, Colo. , Aug. 18, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the arrival of newly appointed CEO, Steven Dyson, and the appointment of several new leaders at the Company.
Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles
Neutral
GlobeNewsWire
2 months ago
Zynex, Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses
Zynex, Inc. Investors: Company Investigated by the Portnoy Law Firm
Neutral
GlobeNewsWire
2 months ago
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zynex, Inc. (NASDAQ:ZYXI) on behalf of long-term stockholders following a class action complaint that was filed against Zynex on July 9, 2025 with a Class Period from March 13, 2023, to the present. Our investigation concerns whether the board of directors of Zynex have breached their fiduciary duties to the company.
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Neutral
The Motley Fool
2 months ago
Zynex Q2 Revenue Drops 55%
Zynex Q2 Revenue Drops 55%
Zynex Q2 Revenue Drops 55%
Neutral
Seeking Alpha
2 months ago
Zynex, Inc. (ZYXI) Q2 2025 Earnings Call Transcript
Zynex, Inc. (NASDAQ:ZYXI ) Q2 2025 Earnings Conference Call July 31, 2025 4:15 PM ET Company Participants Anna Lucsok - Chief Operating Officer Daniel J. Moorhead - Chief Financial Officer Donald Gregg - President of Zynex Monitoring Solutions Thomas Sandgaard - Founder, President, CEO & Chairman Conference Call Participants Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division Shagun Singh Chadha - RBC Capital Markets, Research Division Operator Good afternoon, ladies and gentlemen, and welcome to the Zynex Second Quarter 2025 Earnings Conference Call.
Zynex, Inc. (ZYXI) Q2 2025 Earnings Call Transcript